Scroll
To Top

Archives for: May 22nd, 2018

NORD Issues Statement Regarding House Passage of the Right to Try Act (S.204)

Written by Lisa Sencen on May 22, 2018
Washington, D.C., May 22, 2018 – The National Organization for Rare Disorders (NORD), the leading independent nonprofit organization representing the 30 million Americans with rare diseases, issued the following statement following today’s passage of the Right to Try Act (S.204) in the House of Representatives:
“Today, the House of Representatives passed the… Read More

Richard Pazdur, M.D.: 2018 Public Health Leadership Award Honoree

Written by Lisa Sencen on April 25, 2018

Richard Pazdur, M.D. is the Director of the Food and Drug Administration’s Oncology Center of Excellence (OCE), which leverages the combined skills of the FDA’s regulatory scientists and reviewers with expertise in drugs, biologics and devices to expedite the development of novel cancer products. In his role as director of… Read More

NORD Issues Statement Regarding House Vote on Right to Try

Written by Lisa Sencen on March 22, 2018

Washington, D.C., March 22, 2018 – The National Organization for Rare Disorders (NORD), the leading independent nonprofit organization representing the 30 million Americans with rare diseases, released the following statement regarding last night’s vote in the House of Representatives on the Right to Try Act:

“Last night, the House of Representatives… Read More

NORD Issues Statement Regarding House Vote on Right to Try

Written by Lisa Sencen on March 14, 2018

Washington, D.C., March 14, 2018 – The National Organization for Rare Disorders (NORD), the leading independent nonprofit organization representing the 30 million Americans with rare diseases, released the following statement in regards to last night’s vote in the House of Representatives on the latest version of the Right to Try Act:

“Yesterday… Read More